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The title compound, C12H12BrNO4S, belongs to the class of
substituted thiazolidine-2,4-diones. Compounds of this type
are important starting materials in pharmaceutical chemistry.
The thiazolidine-2,4-dione ring is disordered about a twofold
rotation axis. Geometric parameters, other than those of the
disordered groups, are in the normal ranges.
Comment
Thiazolidine-2,4-dione is used as a starting material for the
synthesis of drugs with antihyperglycemic activity (Zask et al.,
1990). In heterocyclic chemistry, thiazolidine-2,4-diones are
particularly important as a therapeutic agents and have been
thoroughly investigated as PPAR- agonists that led to the
development of several insulin-sensitizing drugs for the
treatment of type-2 diabetes (Blanchet & Zhu, 2004). Diverse
biological activities have been found to be associated with
thiazolidine derivatives (Singh et al., 1981). The present
communication reports the synthesis and crystal structure of a
new thiazolidine-2,4-dione derivative, viz. 3-(2-bromo-4,5-di-
methoxybenzyl)thiazolidine-2,4-dione, (I).
A perspective view of (I) is shown in Fig. 1. Since the
thiazolidine-2,4-dione ring is disordered, it is not appropriate
to discuss its geometric parameters. The dihedral angles
between the two rings are 70.86 (12) and 68.3 (2) for the
major and minor occupied sites, respectively. The Br atom is
displaced away from the neighbouring carbonyl group
[Br12  O2 = 4.126 (4) A˚ and Br12  O20 = 3.549 (14) A˚], as
can be seen by comparing the bond angles involving the C—Br
bond (Table 1). Whereas one of the methoxy groups is almost
coplanar with the aromatic ring, the other one is slightly
displaced from the ring plane.
Experimental
An equimolar mixture of thiazolidine-2,4-dione (1.17 g, 10 mmol), 1-
bromo-2-bromomethyl-4,5-dimethoxybenzene (3.1 g, 10 mmol) and
anhydrous K2CO3 (1.38 g, 10 mmol) was stirred at room temperature
in dimethylformamide (10 ml) for 6 h. The product formed was
crystallized from ethanol. The title compound melts at 420 K. IR
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(KBr,  cm1): 3396 (w), 2939 (s), 2837 (w), 1740 (s), 1668 (s), 1508
(s), 1380 (m), 1213 (m); 1H NMR (CDCl3, p.p.m.): 3.8 (s, 6H, OCH3–),
3.92 (s, 2H, CH2–), 4.89 (s, 2H, CH2–), 6.49 (s, 1H, ArH–), 6.92 (s, 1H,
ArH–); 13C NMR (CDCl3, p.p.m.): 39.2 (t, C2, CH2–), 42.3 (t, C4,
CH2–), 59.1 (q, C42, C52, OCH3–), 116 (s, C11, C—C–), 117.2 (d, C13,
ArCH–), 119.4 (d, C16, ArCH–), 141.1 (s, C12, C—Br–), 145.1 (s,
C15, C—O–), 146.8 (s, C14, C—O–), 167.9 (s, C3, C C–), 168.2 (s,
C1, C O). Analysis calculated for C12H12BrNO4S: C 41.63, H 3.49, N
4.05%; found: C 41.67, H 3.48, N 4.06%.
Crystal data
C12H12BrNO4S
Mr = 346.20
Monoclinic, P21=c
a = 8.6677 (10) A˚
b = 18.5082 (18) A˚
c = 8.9746 (10) A˚
 = 111.950 (9)
V = 1335.4 (3) A˚3
Z = 4
Dx = 1.722 Mg m
3
Mo K radiation
Cell parameters from 7895
reflections
 = 4.2–25.6
 = 3.24 mm1
T = 173 (2) K
Block, colourless
0.36  0.32  0.29 mm
Data collection
Stoe IPDS-II two-circle
diffractometer
! scans
Absorption correction: multi-scan
(MULABS; Spek, 2003;
Blessing, 1995)
Tmin = 0.334, Tmax = 0.390
6240 measured reflections
2486 independent reflections
2242 reflections with I > 2(I)
Rint = 0.023
max = 25.7

h = 9 ! 10
k = 19 ! 22
l = 10 ! 10
Refinement
Refinement on F 2
R[F 2 > 2(F 2)] = 0.032
wR(F 2) = 0.078
S = 1.16
2486 reflections
203 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.0441P)2
+ 0.5152P]
where P = (Fo
2 + 2Fc
2)/3
(/)max = 0.002
max = 0.46 e A˚
3
min = 0.79 e A˚3
Extinction correction: SHELXL97
Extinction coefficient: 0.0107 (12)
Table 1
Selected geometric parameters (A˚, ).
Br12—C12 1.911 (2)
C11—C12—Br12 121.66 (19) C13—C12—Br12 116.37 (18)
C42—O41—C14—C13 0.6 (3) C52—O51—C15—C16 7.1 (4)
The thiazolidine-2,4-dione ring is disordered about an approx-
imate twofold rotation axis running through atom N1 and the CH2—S
bond. The ratio of site-occupation factors of the disordered atoms
refined to 0.740 (5):0.260 (7). The atoms of the minor component
were refined isotropically. Corresponding bond lengths and angles in
the two disordered groups were restrained to be equal. H atoms
(excluding those of the methylene group in the thiazolidine-2,4-dione
ring) were located in a difference map. All H atoms were geome-
trically positioned and refined with fixed individual displacement
parameters [set at 1.2Ueq of the parent atom (1.5Ueq for methyl
groups)] using a riding model, with C—H distances ranging from 0.95
to 0.99 A˚. In addition, the torsion angles about the methyl groups
were refined.
Data collection: X-AREA (Stoe & Cie, 2001); cell refinement:
X-AREA; data reduction: X-AREA; program(s) used to solve
structure: SHELXS97 (Sheldrick, 1990); program(s) used to refine
structure: SHELXL97 (Sheldrick, 1997); molecular graphics: XP in
SHELXTL-Plus (Sheldrick, 1991); software used to prepare material
for publication: SHELXL97 and PLATON (Spek, 2003).
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Figure 1
Perspective view of the title compound with the atom numbering;
displacement ellipsoids are drawn at the 50% probability level.
